| Stage | ACA | % of rev | KAI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $659M | 100.00% | $313M | 100.00% | ACA ×2.11 |
| Gross profit | $156M | 23.64% | $137M | 43.79% | KAI +20.2pp |
| Operating income | $84M | 12.80% | $51M | 16.26% | KAI +3.5pp |
| Pre-tax income | $62M | 9.46% | $46M | 14.71% | KAI +5.3pp |
| Net income | $329M | 49.87% | $33M | 10.50% | ACA +39.4pp |
| Stage | ACA | KAI | Gap · A − B |
|---|---|---|---|
| Revenue | $659M100.00% | $313M100.00% | ACA ×2.11 |
| Gross profit | 23.64%$156M | 43.79%$137M | KAI +20.2pp |
| Operating income | 12.80%$84M | 16.26%$51M | KAI +3.5pp |
| Pre-tax income | 9.46%$62M | 14.71%$46M | KAI +5.3pp |
| Net income |
| 49.87%$329M |
| 10.50%$33M |
| ACA +39.4pp |